Location History:
- Saint-Benoit, FR (2003)
- Poitiers, FR (2011 - 2012)
- Vincennes, FR (2019)
Company Filing History:
5 out of 5,081 
3 out of 58 
1 out of 1,743 
Years Active: 2003-2019
Title: Yvette Mettey: Innovator in Cellular Necroptosis and Anti-Prion Research
Introduction
Yvette Mettey is a prominent inventor based in Poitiers, France. She has made significant contributions to the fields of cellular necroptosis and neurodegenerative diseases. With a total of 5 patents, her work focuses on innovative solutions for treating complex medical conditions.
Latest Patents
Mettey's latest patents include groundbreaking research on Sibiriline derivatives aimed at preventing and treating disorders associated with cellular necroptosis. This invention involves a compound of a specific general formula, which can be used as an inhibitor of cellular necroptosis. Additionally, she has developed a pharmaceutical composition that incorporates this compound for the same therapeutic purposes. Another notable patent involves screening molecules with anti-prion activity. This invention includes kits and methods for identifying molecules that can combat prion diseases, which are linked to neurodegenerative disorders.
Career Highlights
Throughout her career, Yvette Mettey has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Université de Poitiers. Her research has not only advanced scientific understanding but has also paved the way for potential treatments for serious health issues.
Collaborations
Mettey has collaborated with notable colleagues, including Jean-Michel Vierfond. These partnerships have contributed to her innovative research and the development of her patents.
Conclusion
Yvette Mettey's contributions to science and medicine through her patents and research are invaluable. Her work continues to inspire advancements in the treatment of complex diseases.